Published in Acta Physiol Scand on August 14, 1967
Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus. J Physiol (1969) 1.35
Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines. Br J Pharmacol (1977) 1.10
Effects of dopamine analogues and antagonists on carotid body chemosensors in situ. J Physiol (1978) 1.10
Studies on the hypotensive action of alpha-methyldopamine. Br J Pharmacol (1975) 1.06
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats. J Pharmacol Exp Ther (2010) 0.99
Effects of nomifensine in vitro on uptake of 5-hydroxytryptamine and dopamine into human platelets. Br J Clin Pharmacol (1977) 0.95
Regulation of metaraminol efflux from rat heart and salivary gland. Br J Pharmacol (1969) 0.92
Differentiating the rapid actions of cocaine. Nat Rev Neurosci (2011) 0.92
Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro. Br J Pharmacol (1969) 0.83
Arterial catecholamine and enzyme histochemistry in migraine. J Neurol Neurosurg Psychiatry (1968) 0.83
On the existence and function of galanin receptor heteromers in the central nervous system. Front Endocrinol (Lausanne) (2012) 0.82
Brain norepinephrine: evidence that neuronal release is essential for sham rage behavior following brainstem transection in cat. Proc Natl Acad Sci U S A (1969) 0.81
Selective loss of noradrenergic phenotypic characters in neuroblasts of the rat embryo. Proc Natl Acad Sci U S A (1979) 0.81
Monoamine mediation of the morphine-induced activation of mice. Br J Pharmacol (1972) 0.80
Pharmacological properties of centrally-administered agents which interfere with neurotransmitter function: a comparison with the central depressant effects of ouabain. Br J Pharmacol (1973) 0.78
Fat-mobilizing action of amphetamine. J Clin Invest (1968) 0.76
Interaction of cannabis and general anaesthetic agents in mice. Br J Pharmacol (1974) 0.75
The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain. Br J Pharmacol (1979) 0.75
Influence of amineptine on changes of blood pressure evoked by norepinephrine and dopamine. Korean J Intern Med (1991) 0.75
Central neurotransmitter function and its behavioral correlates in man. Environ Health Perspect (1978) 0.75
The interaction between female sex hormones and D-amphetamine on central biogenic amines during the rat oestrous cycle. Ir J Med Sci (1978) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (1993) 9.88
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol (1973) 3.54
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol (1970) 3.54
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med (1997) 3.49
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol (1969) 2.61
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
Drug-induced changes in the release of ( 3 H)-noradrenaline from field stimulated rat iris. Br J Pharmacol (1971) 2.27
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect (1993) 2.20
Cellular localization of monoamines in the area postrema of certain mammals. J Comp Neurol (1965) 2.13
Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol Toxicol (Copenh) (1966) 2.13
Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol (1967) 2.08
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther (2013) 2.01
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease. Trends Neurosci (1990) 1.91
Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg (1985) 1.75
Localization of monoamines in the lower brain stem. Experientia (1964) 1.72
Biochemistry, molecular biology, and physiology of the glucocorticoid receptor. Endocr Rev (1987) 1.68
Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci U S A (1986) 1.61
Modification of sympathetic function. Pharmacological depletion of catecholamine stores. Pharmacol Rev (1966) 1.56
Natural history of postoperative aneurysm rests. J Neurosurg (1987) 1.55
Paravertebral block during cholecystectomy: effects on circulatory and hormonal responses. Br J Anaesth (1988) 1.54
Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol Sci (1999) 1.54
Magnetic resonance imaging of obliterated arteriovenous malformations up to 23 years after radiosurgery. J Neurosurg (1997) 1.53
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A (2000) 1.53
Movement patterns of the C-stem femoral component: an RSA study of 33 primary total hip arthroplasties followed for two years. J Bone Joint Surg Br (2005) 1.53
Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl (1971) 1.51
Intercellular communication in the brain: wiring versus volume transmission. Neuroscience (1995) 1.50
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med (1993) 1.50
Pharmacological studies on the hypotensive effects of clonidine. Eur J Pharmacol (1971) 1.49
High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J (1992) 1.48
Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res (1969) 1.47
A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci (1978) 1.45
Continuous distal migration and internal rotation of the C-stem prosthesis without any adverse clinical effects: an RSA study of 33 primary total hip arthroplasties followed for up to ten years. Bone Joint J (2014) 1.45
Pheochromocytoma: current status and changing trends. Surgery (1982) 1.44
Hypothermic effect of apomorphine in the mouse. J Pharm Pharmacol (1972) 1.43
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry (2000) 1.43
The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur J Surg Oncol (2003) 1.41
Uptake of catecholamines and penetration of trypan blue after blood-brain barrier lesions. A histochemical study. Z Zellforsch Mikrosk Anat (1966) 1.40
Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab (1996) 1.40
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A (1991) 1.39
Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett (1986) 1.38
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia. Science (1974) 1.38
Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons. Neurosci Lett (1975) 1.38
Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev (1966) 1.37
Insect immunity. The primary structure of the antibacterial protein attacin F and its relation to two native attacins from Hyalophora cecropia. EMBO J (1984) 1.35
Oral L-dopa treatment of parkinsonism. Acta Med Scand (1970) 1.35
A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta Physiol Scand (1967) 1.35
Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J Pharm Pharmacol (1969) 1.34
Adrenergic and cholinergic nerve terminals in skeletal muscle vessels. Acta Physiol Scand (1970) 1.34
The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology (1971) 1.33
Ammonia synthesis from first-principles calculations. Science (2005) 1.33
Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci (1970) 1.33
Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology (1985) 1.32
Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.31
ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol (1972) 1.31
Long-term follow-up of replacement compared with internal fixation for displaced femoral neck fractures: results at ten years in a randomised study of 450 patients. J Bone Joint Surg Br (2010) 1.30
Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines. J Pharm Pharmacol (1966) 1.29
On the projections from the locus coeruleus noradrealine neurons: the cerebellar innervation. Brain Res (1971) 1.29
Blood pressure course in patients with acute stroke and matched controls. Stroke (1986) 1.28
Evidence for a new type of dopamine receptor stimulating agent. J Pharm Pharmacol (1971) 1.27
Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol Rev (1972) 1.27
Perspectives on the discovery of central monoaminergic neurotransmission. Annu Rev Neurosci (1987) 1.27
Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology (1972) 1.27
Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol (1975) 1.27
Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A (1979) 1.26
Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res (1972) 1.26
Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition. Eur J Pharmacol (1969) 1.24
Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci (1965) 1.23
The effect of some psychoactive drugs on central monoamine neurons. Eur J Pharmacol (1967) 1.23
Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp Brain Res (1979) 1.22
The effect of immobilization stress on the activity of central monoamine neurons. Life Sci (1968) 1.22
Effects of desipramine, phentolamine and phenoxybenzamine on the release of noradrenaline from isolated tissues. J Pharm Pharmacol (1970) 1.21
Pharmacokinetics and biological effects of nortriptyline in man. Acta Pharmacol Toxicol (Copenh) (1971) 1.21
The effect of imipramine on central 5-hydroxytryptamine neurons. J Pharm Pharmacol (1968) 1.21
Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology (2000) 1.20
The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm (Vienna) (2009) 1.20
Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol (1974) 1.20
Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull (1990) 1.20
The antibacterial effect of attacins from the silk moth Hyalophora cecropia is directed against the outer membrane of Escherichia coli. EMBO J (1984) 1.19
Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.19
The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J Neurosci (1993) 1.18
Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm (1976) 1.18